Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry -: Application to polytraumatized patients

被引:23
作者
Mas, Emilie [1 ]
Michel, Francoise [1 ]
Guy, Alexandre [2 ]
Bultel, Valerie [2 ]
Falquet, Yoan [3 ]
Chardon, Patrick [3 ]
Rossi, Jean-Claude [1 ,2 ]
Cristol, Jean Paul
Durand, Thierry [2 ]
机构
[1] Lapeyronie Hosp, Dept Biochem, F-34295 Montpellier 5, France
[2] CNRS, IBMM, UM 1, Fac Pharm,UMR 5247,UM 2, Montpellier, France
[3] Lapeyronie Hosp, Dept Anesthesiol & Crit Care Med, Montpellier, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 872卷 / 1-2期
关键词
isoprostanes; GC-MS; 15-F-2t-IsoP; 4(RS)-F-4t-NeuroP; polytraurnatized patients;
D O I
10.1016/j.jchromb.2008.07.037
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Isoprostanes are a family of prostaglandin isomers produced from oxidation of polyunsaturated fatty acids through a non-enzymatic free radical-catalyzed mechanism. Quantification of F-2-isoprostanes (F-2-IsoPs) provides a good index of oxidative stress and allows non-invasive assessment of lipid peroxidation in vivo. Since "interferences peaks" at m/z 573 co-elute with d(4)-15-F-2t-IsoP preferentially used, we propose a new GC-NICI-MS approach to quantify urinary F-2-IsoPs by using 4(RS)-F-4t-neuroprostane as the internal standard. This method was applied to quantify urinary F-2-IsoPs excretion in healthy volunteers and polytraumatized patients. Our results showed a significant increase (p < 0.0001) in urinary F-2-IsoPs in polytraumatized patients compared with healthy volunteers (4.73 +/- 2.75 ng/mg vs. 0.811 +/- 0.359 ng/mg creatinine). (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 46 条
  • [1] Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans
    Arneson, Kyle O.
    Roberts, L. Jackson, II
    [J]. LIPIDOMICS AND BIOACTIVE LIPIDS: SPECIALIZED ANALYTICAL METHODS AND LIPIDS IN DISEASE, 2007, 433 : 127 - 143
  • [2] Measurement of urinary 8-epi-prostaglandin F-2 alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction gas chromatography mass spectrometry. Basal levels in smokers and nonsmokers
    Bachi, A
    Zuccato, E
    Baraldi, M
    Fanelli, R
    Chiabrando, C
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (04) : 619 - 624
  • [3] Factors regulating isoprostane formation in vivo
    Basu, S
    Helmersson, J
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (1-2) : 221 - 235
  • [4] Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients
    Bayir, H
    Marion, DW
    Puccio, AM
    Wisniewski, SR
    Janesko, KL
    Clark, RSB
    Kochanek, PM
    [J]. JOURNAL OF NEUROTRAUMA, 2004, 21 (01) : 1 - 8
  • [5] Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children
    Bayir, H
    Kagan, VE
    Tyurina, YY
    Tyurin, V
    Ruppel, RA
    Adelson, PD
    Graham, SH
    Janesko, K
    Clark, RSB
    Kochanek, PM
    [J]. PEDIATRIC RESEARCH, 2002, 51 (05) : 571 - 578
  • [6] Determination of isoprostaglandin F2α type III in human urine by gas chromatography-electronic impact mass spectrometry.: Comparison with enzyme immunoassay
    Bessard, J
    Cracowski, JL
    Stanke-Labesque, F
    Bessard, G
    [J]. JOURNAL OF CHROMATOGRAPHY B, 2001, 754 (02): : 333 - 343
  • [7] Porous graphitic carbon chromatography-tandem mass spectrometry for the study of isoprostanes in human cerebrospinal fluid
    Bohnstedt, KC
    Karlberg, B
    Basun, H
    Schmidt, S
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 827 (01): : 39 - 43
  • [8] Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications
    Cracowski, JL
    Durand, T
    Bessard, G
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) : 360 - 366
  • [9] Potential therapeutic effect of antioxidant therapy in shock and inflammation
    Cuzzorcrea, S
    Thiemermann, C
    Salvemini, D
    [J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (09) : 1147 - 1162
  • [10] Quantification of dinor,dihydro metabolites of F2 isoprostanes in urine by liquid chromatography/tandem mass spectrometry
    Davies, SS
    Zackert, W
    Luo, Y
    Cunningham, CC
    Frisard, M
    Roberts, LJ
    [J]. ANALYTICAL BIOCHEMISTRY, 2006, 348 (02) : 185 - 191